Picture of Neximmune logo

NEXI — Neximmune News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Neximmune Inc reports results for the quarter ended in March - Earnings Summary

* Neximmune Inc  NEXI.OQ  reported a quarterly adjusted loss
of 66
cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 70 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Neximmune Inc's reported EPS for the quarter was a loss
of 66
cents​.
    * The mean earnings estimate of analysts had risen by
about 0.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Neximmune Inc shares had fallen by 52.3% this quarter and
lost 56.4% so far this year.
    * The company reported a quarterly loss of $15.02 million.
    * Wall Street's median 12-month price target for Neximmune
Inc is
$12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 09:02 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Neximmune

See all news